ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,152.70
-1.89%
S&P ASX All Technology
3,786.20
-2.75%
Brent Oil
72.865
0.18%
US Dollar vs AUD
1.60442
-0.45%
Bitcoin
101,124.12
1.06%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Taiwan Liposome Company Ltd (TLC) Share Price

Taiwan Liposome Company Ltd

Taiwan Liposome Company Ltd (TLC)

Lottery Corporation Ltd
7.00
0.00
(0.00%)
Closed 19 December 8:00AM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
7.00
Bid
6.66
Offer
7.10
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
7.00
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

Ask ADVFN Intelligence (AI)

TLC Latest News

More News

Highlights of Dr. David Hunter’s Oral Presentation at ACR’s Late Breaking Abstracts Session

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Professor David Hunter, Florance and Cope Chair of Rheumatology at the University of Sydney, presented detailed...

20 November 2023
GlobeNewswire Inc.

TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACR

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 08, 2023 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a late clinical-stage specialty pharmaceutical company developing novel nanomedicines to...

08 November 2023
GlobeNewswire Inc.

TLC Announces TLC599 Agreement with Endo

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 13, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...

13 June 2022
GlobeNewswire Inc.

TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & Therapy

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, March 07, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target...

07 March 2022
GlobeNewswire Inc.

TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares

This communication does not constitute an offer of any securities for sale or subscription or a solicitation of an offer to purchase or subscribe to any securities in any jurisdiction. The...

08 September 2021
GlobeNewswire Inc.

TLC Reports Second Quarter 2021 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Aug. 12, 2021 (GLOBE NEWSWIRE) -- TLC, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet...

12 August 2021
GlobeNewswire Inc.

TLC Announces Details of Stock Swap Transactions

TAIPEI, Taiwan, July 05, 2021 (GLOBE NEWSWIRE) -- Taiwan Liposome Company (Nasdaq: TLC, TWO: 4152, “the company”), a clinical-stage specialty pharmaceutical company developing novel...

05 July 2021
GlobeNewswire Inc.

TLC and Zydus Enter Agreement to Launch AmphoTLC™ in India

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 26, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...

26 May 2021
GlobeNewswire Inc.

TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in India

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 25, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...

25 May 2021
GlobeNewswire Inc.

InspirMed Highlights Encouraging Data on ISPM21 and ISPM19 – Inhalable Liposome Formulations of Antiviral Drugs for COVID-1...

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 23, 2021 (GLOBE NEWSWIRE) -- InspirMed Inc., a subsidiary of TLC (Nasdaq: TLC, TWO: 4152) that specializes in the development of proprietary...

23 May 2021
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

TLC - Frequently Asked Questions (FAQ)

What is the current Taiwan Liposome share price?
The current share price of Taiwan Liposome is US$ 7.00
What is the 1 year trading range for Taiwan Liposome share price?
Taiwan Liposome has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LITMSnow Lake Resources Ltd
US$ 0.7943
(334.04%)
1.2B
NUKKNukkleus Inc
US$ 50.68
(326.60%)
54.52M
PLRZPolyrizon Ltd
US$ 3.256
(210.10%)
137.32M
QMCOQuantum Corporation
US$ 60.085
(153.31%)
22.66M
VRARGlimpse Group Inc
US$ 3.1885
(100.53%)
55.04M
XCHXCHG Ltd
US$ 2.16
(-90.74%)
11.17M
FTELFitell Corporation
US$ 5.50
(-85.67%)
1.68M
XHGXChange TED Inc
US$ 0.754
(-52.28%)
549.34k
MHUAMeihua International Medical Technologies Company Ltd
US$ 0.2755
(-43.82%)
8.86M
RNAZTransCode Therapeutics Inc
US$ 3.915
(-38.00%)
854.5k
LITMSnow Lake Resources Ltd
US$ 0.7943
(334.04%)
1.19B
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.3671
(9.94%)
312.75M
CGTXCognition Therapeutics Inc
US$ 0.58295
(28.15%)
284.82M
RGTIRigetti Computing Inc
US$ 10.684
(-4.01%)
276.65M
NVDANVIDIA Corporation
US$ 128.91
(-1.14%)
273.75M

TLC Discussion

View Posts
TraderStig TraderStig 3 years ago
#DDAmanda Chart on: $TLC

You can scan for these before they run.



#DDAmanda Promo Code: dsh888

What the Fact (Factor) Column is:

The Factor is a proprietary indicator used for scanning in #DDAmanda.

It's defined as Today's $Traded divided by the average daily $Traded (20 day avg).

SO, if a stock has say a 10 Factor that day, it means she traded 10 Times the $ she normally trades.

That's significant, and many times indicates that a run in the stock is coming.




👍️0
FROZENFLAME FROZENFLAME 4 years ago
$TLC READY FOR SOME NEWS .
👍️0
FROZENFLAME FROZENFLAME 4 years ago
$$$TLC$$$
👍️0
FROZENFLAME FROZENFLAME 4 years ago
https://ir.tlcbio.com/news-releases/news-release-details/tlc-announces-acceptance-manuscript-anti-covid-19-program
👍️0
FROZENFLAME FROZENFLAME 4 years ago
Nice close .
👍️0
FROZENFLAME FROZENFLAME 4 years ago
Hit me with the NEWS !!
👍️0
FROZENFLAME FROZENFLAME 4 years ago
4 weeks almost over, hydroxychloroquine. Study medication is administered through inhalation via a commercially available portable vibrating mesh nebulizer, and all subjects will be followed up for 4 weeks.
👍️0
FROZENFLAME FROZENFLAME 4 years ago
Adding .
👍️0
FROZENFLAME FROZENFLAME 4 years ago
This my baby, I’m adding more tomorrow .
👍️0
FROZENFLAME FROZENFLAME 4 years ago
https://ir.tlcbio.com/news-releases/news-release-details/tlc-announces-appointment-thomas-h-bliss-jr-mba-chief-business
👍️0
FROZENFLAME FROZENFLAME 4 years ago
Adding some more, updates coming soon .
👍️0
FROZENFLAME FROZENFLAME 4 years ago
O/S 5M one more update $10s will be up with no time .
👍️0
FROZENFLAME FROZENFLAME 4 years ago
https://finance.yahoo.com/news/tlc-enrolls-first-subject-phase-084100428.html
👍️0
FROZENFLAME FROZENFLAME 4 years ago
4K shares at $9.00 after hours !!!!
👍️0
FROZENFLAME FROZENFLAME 4 years ago
Huge potential !!!
👍️0
FROZENFLAME FROZENFLAME 4 years ago
Nice close .
👍️0
FROZENFLAME FROZENFLAME 4 years ago
I’m in $$$TLC$$$
👍️0
crudeoil24 crudeoil24 4 years ago

TLC Receives Australian and Taiwan Approval to Initiate Phase I Clinical Trial of TLC19 Inhalable Liposomal Hydroxychloroquine for COVID-19
👍️0
otcmoneydoubler otcmoneydoubler 4 years ago
TLC MOVING ON COVID AUSTRALIAN NEWS
👍️0

Your Recent History

NASDAQ
TLC
Taiwan Liposome
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved